Eosinopenia as an adverse marker of clinical outcomes in patients presenting with acute myocardial infarction.

Link to article at PubMed

Related Articles

Eosinopenia as an adverse marker of clinical outcomes in patients presenting with acute myocardial infarction.

Am J Med. 2019 May 29;:

Authors: Alkhalil M, Kearney A, Hegarty M, Stewart C, Devlin P, Owens CG, Spence MS

BACKGROUND: Eosinopenia is considered a surrogate of inflammation in several disease settings. Following ST- segment elevation myocardial infarction, eosinopenia is presumed to be a marker of infarct severity. We sought to study the relationship between eosinopenia and infarct severity and how this relationship determined the long-term outcomes following ST-segment elevation myocardial infarction.
METHODS: 606 consecutive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention from a large volume single centre were enrolled. Low eosinophil count was defined as <40 cells/ml from samples within 2-h post reperfusion. Primary endpoint was defined as composite of death, myocardial infarction, stroke, unplanned revascularisation, re-admission for heart failure over 3.5years follow up.
RESULTS: 65% of patients had eosinopenia. Patients in the low eosinophil group had larger infarct size as measured by troponin value [2934 vs. 1177ng/L, P<0.001] and left ventricle systolic function on echocardiography [48% vs. 50%, P=0.029]. There was a weak correlation between eosinophil count and both troponin (r=-0.25, P<0.001) and ejection fraction (r=0.10, P=0.017). The primary endpoint was higher in eosinopenic patients (28.8% vs. 20.4%; HR 1.49, 95%CI 1.05 to 2.13, P=0.023). A discordance between eosinopenia and severe left ventricle systolic dysfunction was observed in 55.6% of cases. Compared with normal count, eosinopenia was associated with worse clinical outcomes in patients with non-severe left ventricle dysfunction (24.1% vs. 16.2%; HR 1.58, 95%CI 1.01 to 2.45, P=0.044) but not in those with severe left ventricle dysfunction (42.3% vs. 38.9%; HR 1.10, 95%CI 0.59 to 2.03, P=0.77) (P<0.01 for interaction).
CONCLUSIONS: Eosinopenia is an easily-determined marker that reflects worse clinical outcomes over long term follow up.

PMID: 31152721 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.